Combined chemotherapy with or without interferon alpha N1 (IFN) for advanced malignant melanoma--a randomized pilot phase III study. - Suppr | 超能文献

Combined chemotherapy with or without interferon alpha N1 (IFN) for advanced malignant melanoma--a randomized pilot phase III study.

作者信息

Gorbonova V A, Egorov G N, Perevodchikova N I, Orel N F

出版信息

Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:310-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Combined chemotherapy with or without interferon alpha N1 (IFN) for advanced malignant melanoma--a randomized pilot phase III study.

Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:310-4.

2

[Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].

Med Klin (Munich). 1996 Apr 12;91 Suppl 3:44-9.

3

Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial.

J Clin Oncol. 2002 Mar 15;20(6):1600-7. doi: 10.1200/JCO.2002.20.6.1600.

4

[Treatment of metastasized malignant melanoma].

Praxis (Bern 1994). 2001 Mar 8;90(10):391-6.

5

Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11.

Cancer Biother Radiopharm. 2000 Oct;15(5):487-94. doi: 10.1089/cbr.2000.15.487.

6

Interleukin-2-based biochemotherapy for patients with stage IV melanoma: long-term survivors outside a clinical trial setting.

Oncology. 2007;73(1-2):33-40. doi: 10.1159/000120029. Epub 2008 Mar 10.

7

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.

Br J Cancer. 2000 Mar;82(6):1158-62. doi: 10.1054/bjoc.1999.1056.

8

A phase II study of neoadjuvant biochemotherapy for stage III melanoma.

Cancer. 2002 Jan 15;94(2):470-6. doi: 10.1002/cncr.10186.

9

Temozolomide and cisplatin in avdanced malignant melanoma.

Anticancer Res. 2005 Mar-Apr;25(2B):1441-7.

10

Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma.

Oncol Rep. 2008 Dec;20(6):1533-8.

引用本文的文献

1

Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.